Cytori Therapeutics To Present At The 25th Annual Roth Conference On March 18

Cytori Therapeutics Inc. (NASDAQ: CYTX) will present and provide a corporate update from the 25th Annual Roth Conference on Monday, March 18 at 4:30 PM PT.

The presentation will be webcast and may be accessed under “ Webcasts” under Cytori’s Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® system product family. www.cytori.com

Copyright Business Wire 2010

If you liked this article you might like

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Cytori Therapeutics Stock Sliding on Offering Price Discount

Cytori Therapeutics Stock Sliding on Offering Price Discount

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

Insider Trading Alert - SUNE, NRIM And CYTX Traded By Insiders

Insider Trading Alert - SUNE, NRIM And CYTX Traded By Insiders